![Filippo Montemurro: Intriguing preclinical findings of synergy between fulvestrant and capecitabile in ESR1 tumors](https://oncodaily.com/pub/uploads/2024/06/Montemurro-Dir-Breast-Unit-e1718727854669.png)
Photo of Filippo Montemurro taken from www.irccs.com
Jun 20, 2024, 11:37
Filippo Montemurro: Intriguing preclinical findings of synergy between fulvestrant and capecitabile in ESR1 tumors
Filippo Montemurro, Senior Medical Director at Roche, shared on X:
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer. Very intriguing preclinical findings of synergy between fulvestrant and capecitabile in ESR1 mutant tumors.
Read further
Source: Filippo Montemurro/X
Aug 16, 2024, 06:55